Gene · 586
Papers1,410
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,410
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic analysis reveals potential biomarker candidates in serous ovarian tumors - a preliminary study. | Contemp Oncol (Pozn) | 2025 | 40330446 | PubTator, text mining | PubMed |
| Comprehensive analysis of transcriptome and microbiome in colorectal cancer with synchronous polyp patients. | Front Cell Infect Microbiol | 2025 | 40313460 | PubTator, text mining | PubMed |
| Cancer-Type-Specific DNA Methylation Is a Source of Vulnerability in Liver Cancer Cells. | Cancer Sci | 2025 | 40313132 | PubTator, text mining | PubMed |
| Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesis. | JHEP Rep | 2025 | 40290517 | PubTator, text mining | PubMed |
| Circulating DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. | Sci Rep | 2025 | 40253416 | PubTator, text mining | PubMed |
| Deep sequencing reveals distinct microRNA-mRNA signatures that differentiate pancreatic neuroendocrine tumor from non-diseased pancreas tissue. | BMC Cancer | 2025 | 40217502 | PubTator, text mining | PubMed |
| Circulating Tumor DNA in Addition to Fecal Immunochemical Test in a Dual-Test Colorectal Cancer Screening Approach. | Clin Colorectal Cancer | 2025 | 40204621 | PubTator, text mining | PubMed |
| SIRT5-mediated BCAT1 desuccinylation and stabilization leads to ferroptosis insensitivity and promotes cell proliferation in glioma. | Cell Death Dis | 2025 | 40195331 | PubTator, text mining | PubMed |
| Development of PDAC diagnosis and prognosis evaluation models based on machine learning. | BMC Cancer | 2025 | 40114140 | PubTator, text mining | PubMed |
| A novel necroptosis-related miRNA signature for predicting the prognosis of esophageal cancer and immune infiltration analysis. | Transl Cancer Res | 2025 | 40104746 | PubTator, text mining | PubMed |
| Design, Synthesis and Biological Activity Study of γ-Aminobutyric Acid (GABA) Derivatives Containing Bridged Bicyclic Skeletons as BCAT1 Inhibitors. | Molecules | 2025 | 40005214 | PubTator, text mining | PubMed |
| A novel BCAT1 inhibitor bufalin sensitizes pancreatic cancer cells to chemotherapy. | Genes Dis | 2025 | 39926331 | PubTator, text mining | PubMed |
| A Review on Branched-Chain Amino Acid Aminotransferase (BCAT) Inhibitors: Current Status, Challenges and Perspectives. | Curr Med Chem | 2025 | 39791161 | PubTator, text mining | PubMed |
| Correction: Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia. | Leukemia | 2025 | 39537979 | PubTator, text mining | PubMed |
| Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia. | Leukemia | 2025 | 39455853 | PubTator, text mining | PubMed |
| BCAT1 contributes to the development of TKI-resistant CML. | Cell Oncol (Dordr) | 2025 | 39412615 | PubTator, text mining | PubMed |
| BCAT1 is a NOTCH1 target and sustains the oncogenic function of NOTCH1. | Haematologica | 2025 | 39234857 | PubTator, text mining | PubMed |
| Nutrigenetics and Nutritional Strategies in Systemic Arterial Hypertension: Evidence From a Scoping Review. | Nutr Rev | 2025 | 39164015 | PubTator, text mining | PubMed |
| BCAT1 promotes cell proliferation, migration, and invasion via the PI3K-Akt signaling pathway in oral squamous cell carcinoma. | Oral Dis | 2025 | 39056279 | PubTator, text mining | PubMed |
| BCAT2 Expression in IDC Breast Cancer subtypes: A Weighted Feature-Based Approach to Identify and Rank Associated Genes Across Public Datasets. | Annu Int Conf IEEE Eng Med Biol Soc | 2024 | 40039929 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/586/papers?page=5